Welcome to the international HTA database

Showing [20542 Records] Selected Records [0 Hits] [Clear]

Year	Source	Title
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Vitamin supplementation for hospitalized adults: clinical evidence and guidelines
2013	Agency for Healthcare Research and Quality (AHRQ)	Vitamin, mineral, and multivitamin supplements for the primary prevention of cardiovascular disease and cancer
2016	NIHR Health Technology Assessment programme	VivaScope® 1500 and 3000 systems for detecting and monitoring skin lesions: a systematic review and economic evaluation
2009	HAYES, Inc.	Vivitrol (Injectable Naltrexone) (Alkermes Inc.) for outpatient treatment of alcohol dependence
2008	HAYES, Inc.	ViziLite Plus with TBlue (Zila Inc.) as an adjunct to conventional oral mucosal screening for high-risk patients
2007	Adelaide Health Technology Assessment (AHTA)	VNS therapy system for the treatment of depression
2005	Adelaide Health Technology Assessment (AHTA)	VNS Therapy(TM) System for the treatment of chronic or recurrent treatment-resistant depression in adults
2012	Malaysian Health Technology Assessment (MaHTAS)	VNUS® Radiofrequency Ablation (RFA) for varicose vein
2014	HAYES, Inc.	Vocal fold steroid injection for treatment of dysphonia
2004	Adelaide Health Technology Assessment (AHTA)	Vocera (R) wireless communication
2008	NIHR Horizon Scanning Centre (NIHR HSC)	Voclosporin (LX-211) for non-infectious uveitis
2008	NIHR Horizon Scanning Centre (NIHR HSC)	Voclosporin for moderate to severe plaque psoriasis
1999	Alberta Heritage Foundation for Medical Research (AHFMR)	Voice controlled arthroscopic pump
2016	NIHR Horizon Scanning Centre (NIHR HSC)	Voke 0.45mg inhaler for smoking cessation – first line
2016	NIHR Horizon Scanning Centre (NIHR HSC)	Volanesorsen - familial chylomicronemia syndrome – first line
2013	NIHR Horizon Scanning Centre (NIHR HSC)	Volasertib for acute myeloid leukaemia in patients ineligible for intensive induction therapy – first line
2005	The Swedish Council on Health Technology Assessment (SBU)	Volume and quality - a preliminary study
2014	HAYES, Inc.	Von Hippel-Lindau (VHL) syndrome
2011	HAYES, Inc.	von Willebrand Factor (VWF) gene testing for von Willebrand Disease (VWD)
2016	NIHR Horizon Scanning Centre (NIHR HSC)	Vonicog alfa for severe von Willebrand disease
2020	Agency for Care Effectiveness (ACE)	Vonoprazan for treating helicobacter pylori infection
2010	NIHR Horizon Scanning Centre (NIHR HSC)	Vorapaxar for acute coronary syndrome
2010	NIHR Horizon Scanning Centre (NIHR HSC)	Vorapaxar for secondary prevention of cardiovascular events
2020	The National Health Care Institute (ZIN, Zorginstituut Nederland)	Voretigene neparvovec (Luxturna®) for the treatment of vision loss due to inherited retinal dystrophy with bi-allelic RPE65 mutations (package advice)
2003	Canadian Coordinating Office for Health Technology Assessment (CCOHTA)	Voriconazole
2008	NIHR Horizon Scanning Centre (NIHR HSC)	Vorinostat (Zolinza) for cutaneous T-cell lymphoma - second line
2010	NIHR Horizon Scanning Centre (NIHR HSC)	Vorinostat for refractory multiple myeloma
2015	NIHR Health Technology Assessment programme	Vortioxetine for treating major depressive disorder
2012	NIHR Horizon Scanning Centre (NIHR HSC)	Vosaroxin in combination with cytarabine for acute myeloid leukamaemia
2013	HAYES, Inc.	VPRIV (Velaglucerase Alfa for Injection; Shire Human Genetic Therapies Inc.) for type 1 gaucher disease
2022	Center for Evidence-based Practice (CEP)	VTE chemoprophylaxis for patients undergoing elective spinal surgery
2006	Technology Assessment Unit of the McGill University Health Centre (MUHC)	Wait times at the MUHC. 2: selected divisions of the departments of medicine and surgery. Supplement to report no 26 "Wait times at the MUHC 1"
2006	Technology Assessment Unit of the McGill University Health Centre (MUHC)	Wait times at the MUHC. I: diagnostic imaging, joint replacement, cancer care, sight restoration, cardiac care
2007	Technology Assessment Unit of the McGill University Health Centre (MUHC)	Wait times at the MUHC. No: 3 fracture management.
2008	Technology Assessment Unit of the McGill University Health Centre (MUHC)	Wait times at the MUHC. No: 4 Diagnostic imaging revisited. Adult hospitals of the MUHC.
2006	VA Technology Assessment Program (VATAP)	Wait times for primary hip and knee replacement surgery
2007	Centre Hospitalier de l'Universite de Montreal(CHUM)	Waiting times at CHUM 1: diagnostic imaging, hip and knee replacements,cardiac surgery, cancer care and sight restoration
2006	Danish Centre for Evaluation and Health Technology Assessment (DACEHTA)	Ward rounds - a health technology assessment focused on production of knowledge
2001	Canadian Coordinating Office for Health Technology Assessment (CCOHTA)	Warm-up therapy
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Warming of amniofluid: safety
2012	Canadian Agency for Drugs and Technologies in Health (CADTH)	Watchful dosing of morphine or morphine equivalent dosing in the treatment of chronic non-cancer pain: a review of the clinical evidence
2009	NIHR Horizon Scanning Centre (NIHR HSC)	WATCHMAN left atrial appendage (LAA) closure device for non-valvular atrial fibrillation (AF)
2013	Malaysian Health Technology Assessment (MaHTAS)	Water birth
2004	Canadian Coordinating Office for Health Technology Assessment (CCOHTA)	Water jet systems for surgical dissection and resection
2002	HAYES, Inc.	Water-induced thermotherapy (WIT) for benign prostatic hyperplasia
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Waterless wipes for chemical eye injuries: clinical effectiveness
2006	Institute for Clinical Effectiveness and Health Policy (IECS)	Wavefront analysis in refractive surgery
2015	NIHR Horizon Scanning Centre (NIHR HSC)	WavSTAT4 Optical Biopsy System® for colorectal cancer diagnosis
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Wear compliance and donning/doffing of respiratory protection for bioaerosols or infectious agents: a review of the effectiveness, safety, and guidelines
2009	Adelaide Health Technology Assessment (AHTA)	Wearable artificial kidney (WAK): Portable dialysis for patients with chronic kidney disease
2022	Austrian Institute for Health Technology Assessment (AIHTA)	Wearable cardioverter-defibrillator (WCD) therapy for primary and secondary prevention of sudden cardiac arrest. Update 2022
2016	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	Wearable cardioverter-defibrillator (WCD) therapy in primary and secondary prevention of sudden cardiac arrest in patients at risk
2016	European Network for Health Technology Assessment (EUnetHTA)	Wearable cardioverter-defibrillator (WCD) therapy in primary and secondary prevention of sudden cardiac arrest in patients at risk
2018	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	Wearable cardioverter-defibrillator (WCD) therapy in primary and secondary prevention of sudden cardiac arrest in patients at risk. Update 2018
2010	Blue Cross Blue Shield Association (BCBS)	Wearable cardioverter-defibrillator as a bridge to implantable cardioverter-defibrillator treatment
2008	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	Web-based toolkit to facilitate European collaboration on evidence generation on promising health technologies
2001	Agencia de Evaluacion de Tecnologias Sanitarias (AETS)	WEBLING project: full text web indexes that have been linguistically enhanced and supplemented by services to cross the language barrier (internal report). In cooperation with EU ESPRIT program. IPE-01/i (Internal Report)
2010	Quality Improvement Scotland (NHS QIS )	Weight management programmes for adults
2008	Center for Evidence-based Practice (CEP)	Weight-based dosing nomograms for unfractionated heparin
2010	NIHR Health Technology Assessment programme	Weighting and valuing quality-adjusted life-years using stated preference methods: preliminary results from the Social Value of a QALY Project
2005	NIHR Health Technology Assessment programme	Wessex Epidural Steroids Trial (WEST), primary research
2013	Scottish Health Technologies Group (SHTG)	What approaches have been taken and efforts made to ensure public involvement in decision making relating to potential disinvestment in healthcare interventions and technologies?
2002	New Zealand Health Technology Assessment (NZHTA)	What are the characteristics of repeating vs. non-repeating suicidal presenters to Emergency services? Evidence Tables
2006	NIHR Health Technology Assessment programme	What are the clinical outcome and cost-effectiveness of endoscopy undertaken by nurses when compared with doctors? A Multi-Institution Nurse Endoscopy Trial (MINuET)
2015	NIHR Health Services and Delivery Research programme	What are the determinants of variations in emergency readmission rates and one-year mortality in patients hospitalized with heart failure or chronic obstructive pulmonary disease?
2002	New Zealand Health Technology Assessment (NZHTA)	What are the presenting complaints that should alert clinicians in emergency departments and tertiary mental health settings to the possibility of suicidal ideation/threat/attempts? Evidence Tables
2015	Belgian Health Care Knowledge Centre (KCE)	What are the recommended clinical assessment and screening tests during pregnancy?
2009	Health Services Assessment Collaboration (HSAC)	What assessment tools are used both in New Zealand and in other countries for grading of evidence?
2017	NIHR Health Technology Assessment programme	What carcinoembryonic antigen level should trigger further investigation during colorectal cancer follow-up? A systematic review and secondary analysis of a randomised controlled trial
2002	New Zealand Health Technology Assessment (NZHTA)	What clinical features best determine insulin resistance? Evidence Tables
2009	Institute for Clinical Evaluative Sciences (ICES)	What does it take to make a healthy province? A benchmark study of jurisdictions in Canada and around the world with the highest levels of health and the best health behaviours
2006	German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI)	What effects has the cataract surgery on the development and progression of age-related macular degeneration (AMD)?
2002	New Zealand Health Technology Assessment (NZHTA)	What evidence exists about the safety of physical restraint when used by law enforcement and medical staff to control individuals with acute behavioural disturbance?
2002	New Zealand Health Technology Assessment (NZHTA)	What evidence is there about the use of seclusion or containment for patients presenting with suicidal behaviours at emergency departments, tertiary mental health services or inpatient units? Evidence Tables
2014	NIHR Health Services and Delivery Research programme	What evidence is there for a relationship between organisational features and patient outcomes in congenital heart disease services? A rapid review
2015	NIHR Health Services and Delivery Research programme	What evidence is there on the effectiveness of different models of delivering urgent care? A rapid review
2002	New Zealand Health Technology Assessment (NZHTA)	What factors determine an inpatient admission as opposed to outpatient referral from emergency services? Evidence Tables
2012	Scottish Health Technologies Group (SHTG)	What implications does the organisation of vascular services have for rates of amputation?
2018	NIHR Health Technology Assessment programme	What is the added value of ultrasound joint examination for monitoring synovitis in rheumatoid arthritis and can it be used to guide treatment decisions? A systematic review and cost-effectiveness analysis
2004	NIHR Health Technology Assessment programme	What is the best imaging strategy for acute stroke?
2013	Scottish Health Technologies Group (SHTG)	What is the clinical and cost effectiveness of dynamic elastomeric fabric orthoses (DEFOs) for cerebral palsy?
2012	Scottish Health Technologies Group (SHTG)	What is the clinical and cost effectiveness of human papillomavirus (HPV) testing, followed by liquid-based cytology triage of positive results, in primary screening for cervical cancer?
2012	Scottish Health Technologies Group (SHTG)	What is the clinical and cost effectiveness of microprocessor-controlled artificial knees compared with non-microprocessor-controlled alternatives?
2012	Scottish Health Technologies Group (SHTG)	What is the clinical and cost effectiveness of temporal artery thermometers compared with infrared in-ear thermometers for temperature measurement in routine clinical practice?
2011	Scottish Health Technologies Group (SHTG)	What is the clinical and cost effectiveness of the ThinPrep imager® (HologicTM, Inc) for assisted cervical cytology compared with manual reading of liquid based cytology slides?
2014	Scottish Health Technologies Group (SHTG)	What is the clinical and cost effectiveness of treatment with renal denervation for patients with resistant hypertension?
2015	NIHR Health Technology Assessment programme	What is the clinical effectiveness and cost-effectiveness of conservative interventions for tendinopathy? An overview of systematic reviews of clinical effectiveness and systematic review of economic evaluations
2014	NIHR Health Technology Assessment programme	What is the clinical effectiveness and cost-effectiveness of cytisine compared with varenicline for smoking cessation? A systematic review and economic evaluation
2012	NIHR Health Technology Assessment programme	What is the clinical effectiveness and cost-effectiveness of using drugs in treating obese patients in primary care? A systematic review
2013	Scottish Health Technologies Group (SHTG)	What is the clinical effectiveness, cost effectiveness and implications for safety of assessing anti-tumour necrosis factor (TNF)α drug levels and antibodies in children with moderate to severe inflammatory bowel disease compared with existing clinical strategies in use in NHS Scotland?
2015	NIHR Public Health Research (PHR) programme	What is the effect of reduced street lighting on crime and road traffic injuries at night? A mixed-methods study
2000	Centre for Clinical Effectiveness (CCE)	What is the effectiveness of a dressing moistened with sodium hypochlorite (Dakins) solution compared to other dressings in improving wound healing?
2001	Centre for Clinical Effectiveness (CCE)	What is the effectiveness of Botulinum Toxin A in the reduction of upper limb spasticity in children with cerebral palsy?
2002	New Zealand Health Technology Assessment (NZHTA)	What is the effectiveness of day care versus outpatient care versus community care for suicidal patients? Evidence Tables
2001	Centre for Clinical Effectiveness (CCE)	What is the effectiveness of octreotide in the management of enteric and pancreatic fistula?
2020	NIHR Health Technology Assessment programme	What is the effectiveness of varenicline compared with nicotine replacement therapy for long term smoking cessation and clinically important outcomes such as mortality, myocardial infarction and frequency of service use? Evidence from the Clinical Practice Research Datalink
2002	New Zealand Health Technology Assessment (NZHTA)	What is the efficacy of crisis interventions? Evidence Tables
2002	New Zealand Health Technology Assessment (NZHTA)	What is the efficacy of discharge planning protocols, i.e., managing the transition from hospital to community? What should be included in the plan? Evidence Tables
2011	Scottish Health Technologies Group (SHTG)	What is the evidence base for the use of orthopaedic spinal surgery for mechanical low back pain or degenerative spondylolisthesis?
2013	Scottish Health Technologies Group (SHTG)	What is the evidence for the clinical and cost effectiveness of major trauma centres as the core component of a trauma service, compared with standard care for adults with major trauma?